Bind opens its Submit a Target initiative

Got an IDP target? We’d love to hear from you.

Intrinsically disordered proteins are implicated in some of the most important and least-treated diseases in human health, but for a long time the tools to drug them simply didn’t exist. At Bind, we’re building those tools, and we want to put them to work on the targets that matter most.

That’s why we’ve launched our Submit an IDP Target initiative. Whether you’re an academic researcher with a target you’ve been unable to pursue through conventional approaches, a clinician who sees an unmet need, a patient foundation with a disease focus, or a company looking for a collaborative partner, we want to hear from you.

There’s no fixed template for what a good submission looks like. If you have a disordered protein you believe is therapeutically relevant or scientifically intriguing, whether in oncology, neurodegeneration, infectious disease or another area, we’re open to a conversation. We’ll review submissions and explore where there’s potential for collaboration using Bind’s screening and characterisation capabilities.